Superluminal Medicines
Waltham, US · Founded 2023 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
CR
CATHERINE RIESENExecutive Officer
CD
CONY D'CRUZExecutive Officer, Director, Promoter
CR
CRAIG RANDALLExecutive Officer
DX
DIAMANTIS XYLASDirector
DM
DYLAN MORRISDirector
AL
ANDREW LEVINDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5MraisedAug 2025 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DYLAN MORRISDirector
- ANDREW LEVINDirector
- DIAMANTIS XYLASDirector
- CONY D'CRUZExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$20MraisedSep 2024 · 12 investors · BiotechnologyRule 506(b)
▶$20MraisedSep 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DIAMANTIS XYLASDirector
- DYLAN MORRISDirector
- CATHERINE RIESENExecutive Officer
- CONY D'CRUZExecutive Officer, Director, Promoter
- ANDREW LEVINDirector
- Offering amount
- $120M
- Amount sold
- $20M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$25.7MraisedAug 2023 · 7 investors · BiotechnologyRule 506(b)
▶$25.7MraisedAug 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CATHERINE RIESENExecutive Officer
- ANDREW LEVINDirector
- CRAIG RANDALLExecutive Officer
- CONY D'CRUZExecutive Officer, Director, Promoter
- DYLAN MORRISDirector
- Offering amount
- $25.7M
- Amount sold
- $25.7M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.